Attendees (who signed attendance sheet)
Pam Howard, Holly Oz, Rose Baker, Mary Kessler, David Mozingo, Nicole Gibran, Lynn Solem, Bruce Cairns, David Voight, John Hunt, Robert Spence, Johanna Sanders, James Jeng, Tina Palmieri, Jeffrey Saffle, Richard Gamelli, Susan Hatfield, Lee Faucher, Barbara Latenser, David Greenhalgh, Debra Reilly, Richard Kagan, Michael Peck, Charles Yowler, Paul Edwards, Bryan Hildebrand, Steve Morris, Steve Wolf, Linda Edelman
Overview of the last year, Jeffrey Saffle MD
Discussion: Dr. Saffle welcomed attendees and reviewed accomplishments of the past year.
- Dr. Kagan announced that a manuscript is being submitted on DRG 483.
- Dr. Palmieri reported on the results of the blood transfusion standards survey
- Oxandrolone study in process
Oxandrolone study report, Linda Edelman RN, MPhil
Discussion: The Oxandrolone study is currently in process. Dr. Steve Wolf is the principal investigator and Linda Edelman is the study coordinator. At this time, 66 patients from 12 sites have been enrolled. A total of 15 sites have received IRB approval to participate in the study. Reported adverse events were reported and discussed. A list of adverse events is attached. It is imperative that all sites email or fax Linda adverse events as they occur. An interim analysis will be performed by Dr. Jeng after 75 patients have completed the study. We hope to conduct the interim analysis this summer. Please mail copies of completed CRF’s (minus patient identifying information) to Linda as soon as possible.
Future Studies
Discussion: A number of potential studies were discussed. Please contact the investigators if interested in participating.
- IV-IG in TENS – Joel Fish, Jeffrey Saffle
- Abdominal Compartment Syndrome – Barbara Latensor
- Transfusion study – Tina Palmieri
- XIGRIS – Nathan Kemalyan
- DRG 272 – Richard Kagan
- Ghrelin.– David Voight
Please contact the principal investigators of this project if you have questions about the above protocols. Protocols will be presented to investigators as they are finalized. Individual sites may choose to participate in all or some of the studies discussed.
Next Meeting
Discussion: The next meeting will be held early this fall (possibly at the ACS). Participants with future study ideas should submit short study protocols to Dr. Saffle for consideration at this meeting. |
